| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |